Zuclopenthixol
- PMID: 30000827
- Bookshelf ID: NBK501768
Zuclopenthixol
Excerpt
Zuclopenthixol is not approved for marketing in the United States, by the U.S. Food and Drug Administration, but is available in other countries. Limited information indicates that maternal oral doses of up to 50 mg daily or depot injections of 72 mg every 2 weeks produce low levels in breastmilk and no detectable short-term adverse effects in the breastfed infants. No long-term data are available. One international guideline recommends that women taking zuclopenthixol not breastfeed.[1] However, a safety scoring system finds zuclopenthixol possible to use cautiously during breastfeeding.[2] Until more data are available, zuclopenthixol should be used with careful infant monitoring during breastfeeding.
Similar articles
-
Moclobemide.2021 May 17. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 May 17. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000824 Free Books & Documents. Review.
-
Mianserin.2022 Apr 18. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2022 Apr 18. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000823 Free Books & Documents. Review.
-
Flupenthixol.2022 Nov 30. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2022 Nov 30. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000822 Free Books & Documents. Review.
-
Trazodone.2022 Apr 18. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2022 Apr 18. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000237 Free Books & Documents. Review.
-
Zuclopenthixol dihydrochloride for schizophrenia.Cochrane Database Syst Rev. 2017 Nov 16;11(11):CD005474. doi: 10.1002/14651858.CD005474.pub2. Cochrane Database Syst Rev. 2017. PMID: 29144549 Free PMC article. Review.
References
-
- Hasan A, Falkai P, Wobrock T, et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 management of special circumstances: Depression, suicidality, substance use disorders and pregnancy and lactation. World J Biol Psychiatry. 2015;16:142–70. - PubMed
-
- Uguz F. A new safety scoring system for the use of psychotropic drugs during lactation. Am J Ther. 2021;28:e118–e126. - PubMed
-
- Aaes-Jørgensen T, Bjørndal F, Bartels U. Zuclopenthixol levels in serum and breast milk. Psychopharmacology (Berl) 1986;90:417–8. - PubMed
-
- Matheson I, Skjaeraasen J. Milk concentrations of flupenthixol, nortriptyline and zuclopenthixol and between-breast differences in two patients. Eur J Clin Pharmacol. 1988;35:217–20. - PubMed
Publication types
LinkOut - more resources
Full Text Sources